Recent

% | $
Quotes you view appear here for quick access.

Shire plc Message Board

  • blackoutbuzz blackoutbuzz Mar 26, 2013 12:09 AM Flag

    Another addition to the pipeline for $160M

    Steady rate of acquisitions to enable future growth

    -----------------------
    Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that it will acquire SARcode Bioscience Inc., a privately held biopharmaceutical company based in Brisbane, California. This acquisition continues to build Shire's presence in the ophthalmology therapeutic category and brings a new phase 3 compound - LIFITEGRAST - currently under development for the signs and symptoms of dry eye disease, into Shire's portfolio. Shire anticipates launching LIFITEGRAST in the United States as early as 2016 pending a positive outcome of the phase 3 clinical development program and regulatory approvals. Shire is acquiring the global rights to LIFITEGRAST and will evaluate an appropriate regulatory filing strategy for markets outside of the United States.